The largest database of trusted experimental protocols

Hif 2α

Manufactured by Qiagen
Sourced in Netherlands

HIF-2α is a laboratory equipment product manufactured by Qiagen. It is used for the detection and quantification of the HIF-2α protein, which is a transcription factor that plays a role in cellular response to hypoxia. The product provides researchers with a tool to study HIF-2α expression and its involvement in various biological processes.

Automatically generated - may contain errors

3 protocols using hif 2α

1

Silencing HIF-1α and HIF-2α in CB-MNCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated CB-MNCs were transfected with dssiRNA HIF-1α and HIF-2α (Qiagen, Venlo, Netherlands) using ‘Human monocyte nucleofactor kit' (Lonza, VPA-1007). Briefly, for each condition an equal amount of CB-MNCs was centrifuged, and 100 μl nucleofactor was added to the cell pellet. From both dssiRNA HIF-1α and HIF- 2α, 1 μg was added to the cell suspension, and transferred to the cuvette and placed in the electroporation system (Amaxa, Lonza Verviers) according to the manufacturer. Transfected CB-MNCs were resuspended in complete EGM medium, transferred to 0.1% gelatin coated wells, and further cultured under 1% O2 according the CB-ECFC culture protocol. Mock transfected cells (only electroporation step, no dssiRNA transfection) served as a control in 20 and 1% O2. Further details are given in Nauta et al. (30 (link)).
+ Open protocol
+ Expand
2

Knockdown of CTBP and HIF-2α in hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
hESCs maintained on Matrigel at 5% oxygen were passaged and incubated overnight. For each transfection, 50 nM siRNA (CTBP1/2 [Ambion]; CTBP1 [Ambion]; CTBP2 [Ambion]; HIF-2α [QIAGEN]), along with 12 μL INTERFERin for CTBP siRNAs (Polyplus) or HiPerFect for HIF-2α siRNA (QIAGEN) transfection reagent were mixed in 200 μL of KnockOut DMEM (Invitrogen) and added in a drop-wise manner to 1 well of a 6-well plate. Cells were harvested 48 h post-transfection and RNA or protein extracted. Allstars control siRNA (QIAGEN) that has no homology to any known mammalian gene was used as a negative control for each transfection.
For double knockdowns (CTBP1+2 siRNA), 50 nM of each siRNA and 12 μL InterferIN transfection reagent were added to 200 μL of KnockOut DMEM. Twice the volume of Allstars negative control siRNA was added to the controls.
+ Open protocol
+ Expand
3

Hypoxia Signaling Pathway Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
U2OS cells were transfected with control siRNA (10 nM; 5′- UUCUCCGAACGUGUCACGU -3′) or siRNA against Arnt (5′-GGAACAAGAUGACAGCCUATT -3′), Miz-1 (5′- GCCUCAUCAGCCUGCUGAATT -3′), Hif1α (5′- GAAGAACUAUGAACAUAAATT -3′) and Hif2α (5′- CGGAUAGACUUAUUGCCAATT -3′) (Qiagen) using the HiPerFect transfection reagent (Qiagen) according to the manufacturer’s instructions. The cells were cultured for 48 hours and then placed at 21% or 1% O2 for 6 hours before harvested.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!